Balancing ischaemia and bleeding risks with novel oral anticoagulants
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Balancing ischaemia and bleeding risks with novel oral anticoagulants
Authors
Keywords
-
Journal
Nature Reviews Cardiology
Volume 11, Issue 12, Pages 693-703
Publisher
Springer Nature
Online
2014-11-04
DOI
10.1038/nrcardio.2014.170
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis
- (2014) Mitesh Shah et al. CIRCULATION
- Lack of Concordance Between Empirical Scores and Physician Assessments of Stroke and Bleeding Risk in Atrial Fibrillation
- (2014) Benjamin A. Steinberg et al. CIRCULATION
- Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation
- (2014) Juan Jesús Carrero et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable
- (2013) Stuart J. Connolly ANNALS OF INTERNAL MEDICINE
- Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
- (2013) Sam Schulman et al. CIRCULATION
- New Oral Anticoagulants: Comparative Pharmacology with Vitamin K Antagonists
- (2013) Francesco Scaglione CLINICAL PHARMACOKINETICS
- New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis
- (2013) J. Oldgren et al. EUROPEAN HEART JOURNAL
- Novel oral anticoagulants: clinical pharmacology, indications and practical considerations
- (2013) Sebastian Harder et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Novel Oral Anticoagulants Versus Warfarin Therapy at Various Levels of Anticoagulation Control in Atrial Fibrillation—A Cost-Effectiveness Analysis
- (2013) Joyce H. S. You JOURNAL OF GENERAL INTERNAL MEDICINE
- Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51
- (2013) C. Michael Gibson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis
- (2013) T. van der Hulle et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
- (2013) Willem JM Dewilde et al. LANCET
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
- (2013) Peter Libby NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
- (2013) Amanda R. Harrington et al. STROKE
- Oral Anticoagulant Therapy
- (2012) Walter Ageno et al. CHEST
- Use of the CHA 2 DS 2 -VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation
- (2012) Deirdre A. Lane et al. CIRCULATION
- Comparative Efficacy and Safety of New Oral Anticoagulants in Patients With Atrial Fibrillation
- (2012) Sebastian Schneeweiss et al.
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2012) Stefan H. Hohnloser et al. EUROPEAN HEART JOURNAL
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
- (2012) Hani Jneid et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes
- (2012) Raffaele De Caterina et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
- (2012) Patrick T. O'Gara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study
- (2012) Marcello Tonelli et al. LANCET
- Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
- (2012) Mark J Alberts et al. LANCET NEUROLOGY
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
- (2012) Jonas Bjerring Olesen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran Etexilate
- (2011) Graeme J. Hankey et al. CIRCULATION
- Standardized Bleeding Definitions for Cardiovascular Clinical Trials
- (2011) Roxana Mehran et al. CIRCULATION
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
- (2011) K. A. A. Fox et al. EUROPEAN HEART JOURNAL
- Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
- (2011) J. Oldgren et al. EUROPEAN HEART JOURNAL
- Impact of Bleeding on Mortality After Percutaneous Coronary Intervention
- (2011) Roxana Mehran et al. JACC-Cardiovascular Interventions
- Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation
- (2011) Ricarda Marinigh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A New Risk Scheme to Predict Warfarin-Associated Hemorrhage
- (2011) Margaret C. Fang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
- (2011) John H. Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
- (2011) Amitava Banerjee et al. THROMBOSIS AND HAEMOSTASIS
- Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)
- (2010) Elsayed Z. Soliman et al. AMERICAN HEART JOURNAL
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Risk-Adjusted Percent Time in Therapeutic Range as a Quality Indicator for Outpatient Oral Anticoagulation
- (2010) Adam J. Rose et al.
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
- (2010) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
- (2010) Lars Wallentin et al. LANCET
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay
- (2010) Zhaoqing Wang et al. THROMBOSIS AND HAEMOSTASIS
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
- (2009) CIRCULATION
- In-Hospital and 1-Year Outcomes Among Percutaneous Coronary Intervention Patients With Chronic Kidney Disease in the Era of Drug-Eluting Stents
- (2009) Faisal Latif et al. JACC-Cardiovascular Interventions
- Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
- (2009) JL Mega et al. LANCET
- Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
- (2009) Alexander GG Turpie et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement
- (2009) Michael Rud Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetics of Oral Anticoagulants
- (2008) Simone Stehle et al. CLINICAL PHARMACOKINETICS
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
- (2008) Michael R. Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now